U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Tue Apr 01 23:33:34 GMT 2025
Edited
by admin
on Tue Apr 01 23:33:34 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
YE8XXF1SDZ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
obrindatamab [INN]
Preferred Name English
OBRINDATAMAB
INN  
Official Name English
MGD-009
Code English
Obrindatamab [WHO-DD]
Common Name English
DUAL-AFFINITY B7-H3/CD3-TARGETED PROTEIN MGD009
Common Name English
MGD009
Code English
Code System Code Type Description
FDA UNII
YE8XXF1SDZ
Created by admin on Tue Apr 01 23:33:34 GMT 2025 , Edited by admin on Tue Apr 01 23:33:34 GMT 2025
PRIMARY
INN
11181
Created by admin on Tue Apr 01 23:33:34 GMT 2025 , Edited by admin on Tue Apr 01 23:33:34 GMT 2025
PRIMARY
NCI_THESAURUS
C136983
Created by admin on Tue Apr 01 23:33:34 GMT 2025 , Edited by admin on Tue Apr 01 23:33:34 GMT 2025
PRIMARY
CAS
2069959-72-2
Created by admin on Tue Apr 01 23:33:34 GMT 2025 , Edited by admin on Tue Apr 01 23:33:34 GMT 2025
PRIMARY
SMS_ID
300000008766
Created by admin on Tue Apr 01 23:33:34 GMT 2025 , Edited by admin on Tue Apr 01 23:33:34 GMT 2025
PRIMARY
From To
1_23 1_88
1_137 1_213
1_283 3_6
1_286 3_9
2_22 2_90
1_318 1_378
1_424 1_482
2_140 2_214
1_243 2_243
3_41 3_101
3_147 3_205
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_354
N 3_77
Related Record Type Details
TARGET->LIGAND
TARGET -> ACTIVATOR
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID REMOVAL [1_504] [3_227] C-TERMINUS LYSINE K3Z4F929H6
AMINO_ACID_SUBSTITUTION [2_1] N-TERMINUS PIDOLIC ACID SZB83O1W42
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL